Valuation: Anupam Rasayan India Ltd

Market Cap 137B 1.43B 1.25B 1.18B 1.07B 2.01B 2.02B 14.13B 5.45B 69.9B 5.38B 5.26B 225B P/E 2027 *
49.7x
P/E 2028 * 32.2x
Enterprise Value 154B 1.6B 1.4B 1.32B 1.2B 2.24B 2.25B 15.79B 6.09B 78.11B 6.01B 5.88B 251B EV / Sales 2027 *
4.5x
EV / Sales 2028 * 3.79x
Free-Float
16.06%
Yield 2027 *
0.17%
Yield 2028 * 0.24%
09-09 Tanfac Industries Limited announced that it has received INR 994.098627 million in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited and other investor. CI
09-07 Anupam Rasayan India Ltd Appoints Hetvi Vyas, as Deputy Chief Financial Officer and Key Managerial Personnel CI
09-05 Anupam Rasayan India Limited Secures Chemical Supply Contract With Major Speciality Metal Manufacturer CI
08-15 Anupam Rasayan India Ltd, Q1 2027 Earnings Call, Aug 14, 2026
08-14 Anupam Rasayan India Ltd Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
08-14 Anupam Rasayan India Limited Announces Appointment of Ravi Desai to Chief Operating Officer, Effective August 14, 2026 CI
08-10 Anupam Rasayan India Ltd completed the acquisition of 0.001% stake in Bliss GVS Pharma Limited for INR 0.5 million. CI
07-17 Anupam Rasayan India Ltd acquired Mates Visa Consultancy Private Limited for INR 0.01 million. CI
07-15 Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million CI
07-06 Tanfac Industries Limited announced that it expects to receive INR 1.734873 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited and other investor. CI
06-11 Anupam Rasayan India Limited Commercialises ETFA Using Flow Chemistry CI
06-04 Crisil Places Anupam Rasayan Ratings on Watch Developing After Bliss GVS Acquisition Announcement MT
05-25 Anupam Rasayan India Ltd, Q4 2026 Earnings Call, May 25, 2026
1 day+2.23%
1 week-0.96%
Current month-4.36%
1 month-1.44%
3 months-5.43%
6 months-2.88%
Current year-8.43%
1 week 1,115.8
Extreme 1115.8
1,227.3
1 month 1,115.8
Extreme 1115.8
1,273.9
Current year 1,115.8
Extreme 1115.8
1,415
1 year 1,045.2
Extreme 1045.2
1,415
3 years 601
Extreme 601
1,415
5 years 546.75
Extreme 546.75
1,415
10 years 474
Extreme 474
1,415
Manager TitleAgeSince
Chief Executive Officer - 11/09/2023
Director of Finance/CFO 36 15/03/2022
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 50 23/04/2013
Director/Board Member 52 01/01/1992
Chairman 77 31/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.23%-0.96%+12.03%+28.55% 1.43B
-0.82%-2.43%+1.50%+52.83% 75.54B
-0.64%+2.69%-1.99%+14.77% 36.43B
-1.22%-1.38%+1.36%-23.69% 35.55B
-0.51%+3.07%-6.47%+9.43% 25.32B
-1.36%+0.38%+38.24%+25.04% 22.7B
-5.68%-3.09%+55.79%+12.92% 19.34B
+0.43%+1.59%-44.94%-42.25% 17.42B
-0.68%+5.52%-0.97%+66.44% 14.31B
-1.20%+2.09%+17.56%-0.04% 13.96B
Average -0.94%+0.96%+7.21%+14.40% 26.2B
Weighted average by Cap. -1.14%+0.26%+5.11%+19.08%

Financials

2027 *2028 *
Net sales 34.12B 356M 310M 293M 266M 498M 500M 3.51B 1.35B 17.35B 1.34B 1.31B 55.82B 40.04B 417M 364M 344M 312M 585M 587M 4.12B 1.59B 20.36B 1.57B 1.53B 65.5B
Net income 2.74B 28.57M 24.91M 23.52M 21.36M 40.02M 40.18M 282M 109M 1.39B 107M 105M 4.48B 4.22B 43.95M 38.32M 36.19M 32.86M 61.56M 61.82M 433M 167M 2.14B 165M 161M 6.9B
Net Debt 16.14B 168M 147M 138M 126M 236M 237M 1.66B 640M 8.2B 632M 618M 26.4B 14.27B 149M 130M 122M 111M 208M 209M 1.47B 566M 7.26B 559M 546M 23.35B
Logo Anupam Rasayan India Ltd
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Employees
2,501
Date Price Change Volume
18/09/26 ₹1,207.70 +2.23% 465,185
17/09/26 ₹1,181.30 +0.25% 277,685
16/09/26 ₹1,178.30 +0.67% 435,775
15/09/26 ₹1,170.40 -4.02% 493,232
11/09/26 ₹1,219.40 -0.95% 418,693
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
1,207.70INR
Average target price
1,215.71INR
Spread / Average Target
+0.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANURAS Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!